Link to the Show / Show NotesArthritisCentral News and Views #5 (11 MB)
- Dr. Rutstein discusses the latest developments regarding the suspension
of Bextra. He addresses the additional black-box warnings to be required on
all anti-inflammatory medications (NSAIDS), even including over-the-counter
products
- News on a Lidoderm patch applied to the knees for osteoarthritis compared
with Celebrex
- Warning about unproven remedies, which are being touted following all of
the controversy with Vioxx, Bextra, and Celebrex
- The potential benefits of Lyrica (pregabalin) in Fibromyalgia
